Annexon (ANNX) awards stock options and RSUs to EVP Ted Yednock

Rhea-AI Filing Summary

Annexon, Inc. reported that EVP & Chief Innovation Officer Ted Yednock acquired new equity awards. He received a stock option for 250,000 shares of common stock at an exercise price of $0.00 per share, vesting in equal monthly installments over four years starting on February 19, 2026.

He also received 62,500 restricted stock units, each RSU converting into one share of common stock upon vesting. One-third of these RSUs vest annually on February 19 of each year, with the first one-third vesting on February 19, 2027, subject to his continued service with the company.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Yednock Ted

Role EVP & CHIEF INNOVATION OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	250,000	$0.00	--
Grant/Award	Common Stock	62,500	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 250,000 shares (Direct); Common Stock — 159,727 shares (Direct)

Footnotes (1)

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yednock Ted

(Last) (First) (Middle)

C/O ANNEXON, INC

1400 SIERRA POINT PKWY, BLDG C, STE 200

(Street)

BRISBANE CA 94005

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Annexon, Inc. [ ANNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CHIEF INNOVATION OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		A		62,500(1)	A	$0	159,727	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$5.1	02/19/2026		A		250,000		(2)	02/19/2036	Common Stock	250,000	$0	250,000	D

Explanation of Responses:

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

2. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

	/s/ Jennifer Lew, Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Annexon (ANNX) executive Ted Yednock receive in this Form 4 filing?

Ted Yednock received a grant of stock options and restricted stock units from Annexon. The award includes 250,000 stock options and 62,500 RSUs, aligning his compensation with company performance through equity that vests over time, subject to his continued service.

How many stock options were granted to Ted Yednock by Annexon (ANNX)?

Annexon granted Ted Yednock stock options for 250,000 shares of common stock. These options have a stated exercise price of $0.00 per share and vest in equal monthly installments over four years starting on February 19, 2026, contingent on continued service.

What is the vesting schedule for Ted Yednock’s restricted stock units at Annexon (ANNX)?

Ted Yednock’s 62,500 RSUs vest in three annual installments. One-third of the RSUs vest each year on February 19, beginning on February 19, 2027. Vesting is conditioned on his continuous service with Annexon through each applicable vesting date.

How do Ted Yednock’s Annexon (ANNX) stock options vest over time?

The 250,000 Annexon stock options granted to Ted Yednock vest monthly. One-forty-eighth of the shares vests on each monthly anniversary of February 19, 2026, so the options are fully vested and exercisable after four years of continuous service.

Does the Annexon (ANNX) Form 4 show a stock purchase or a compensation grant?

The Form 4 reflects a compensation grant, not an open-market purchase. Ted Yednock acquired both stock options and RSUs as awards from Annexon, with no cash purchase price and vesting schedules tied to his ongoing employment with the company.

What ownership does Ted Yednock report after these Annexon (ANNX) equity grants?

Following the reported RSU-related common stock grant, Ted Yednock directly holds 159,727 shares of Annexon common stock. This figure reflects his direct ownership position after the award, separate from the 250,000 stock options that vest over time.